186 related articles for article (PubMed ID: 37927213)
1. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.
Streitfeld WS; Dalton AC; Howley BV; Howe PH
Cancer Biol Ther; 2023 Dec; 24(1):2271638. PubMed ID: 37927213
[TBL] [Abstract][Full Text] [Related]
2. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
3. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
[TBL] [Abstract][Full Text] [Related]
4. Opposing Roles of Acetylation and Phosphorylation in LIFR-Dependent Self-Renewal Growth Signaling in Mouse Embryonic Stem Cells.
Wang XJ; Qiao Y; Xiao MM; Wang L; Chen J; Lv W; Xu L; Li Y; Wang Y; Tan MD; Huang C; Li J; Zhao TC; Hou Z; Jing N; Chin YE
Cell Rep; 2017 Jan; 18(4):933-946. PubMed ID: 28122243
[TBL] [Abstract][Full Text] [Related]
5. The ILEI/LIFR complex induces EMT via the Akt and ERK pathways in renal interstitial fibrosis.
Zhou J; Jiang H; Jiang H; Fan Y; Zhang J; Ma X; Yang X; Sun Y; Zhao X
J Transl Med; 2022 Jan; 20(1):54. PubMed ID: 35093095
[TBL] [Abstract][Full Text] [Related]
6. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations.
Kosfeld A; Brand F; Weiss AC; Kreuzer M; Goerk M; Martens H; Schubert S; Schäfer AK; Riehmer V; Hennies I; Bräsen JH; Pape L; Amann K; Krogvold L; Bjerre A; Daniel C; Kispert A; Haffner D; Weber RG
Hum Mol Genet; 2017 May; 26(9):1716-1731. PubMed ID: 28334964
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
9. Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.
Zhang W; Shi X; Chen R; Zhu Y; Peng S; Chang Y; Nian X; Xiao G; Fang Z; Li Y; Cao Z; Zhao L; Liu G; Sun Y; Ren S
Mol Ther; 2020 Nov; 28(11):2473-2487. PubMed ID: 32592689
[TBL] [Abstract][Full Text] [Related]
10. Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.
Lei C; Lv S; Wang H; Liu C; Zhai Q; Wang S; Cai G; Lu D; Sun Z; Wei Q
DNA Cell Biol; 2018 Aug; 37(8):659-669. PubMed ID: 29902078
[TBL] [Abstract][Full Text] [Related]
11. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
12. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.
Dahéron L; Opitz SL; Zaehres H; Lensch MW; Andrews PW; Itskovitz-Eldor J; Daley GQ
Stem Cells; 2004; 22(5):770-8. PubMed ID: 15342941
[TBL] [Abstract][Full Text] [Related]
13. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
14. Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis.
Kral M; Klimek C; Kutay B; Timelthaler G; Lendl T; Neuditschko B; Gerner C; Sibilia M; Csiszar A
FEBS J; 2017 Oct; 284(20):3484-3505. PubMed ID: 28837266
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1).
Noguchi K; Dincman TA; Dalton AC; Howley BV; McCall BJ; Mohanty BK; Howe PH
J Biol Chem; 2018 Jul; 293(29):11401-11414. PubMed ID: 29871931
[TBL] [Abstract][Full Text] [Related]
17. LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling.
Sasaki N; Shinomi M; Hirano K; Ui-Tei K; Nishihara S
Stem Cells; 2011 Apr; 29(4):641-50. PubMed ID: 21305673
[TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.
Lv S; Ji L; Chen B; Liu S; Lei C; Liu X; Qi X; Wang Y; Lai-Han Leung E; Wang H; Zhang L; Yu X; Liu Z; Wei Q; Lu L
Oncogene; 2018 Mar; 37(10):1354-1368. PubMed ID: 29269867
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
Underhill-Day N; Heath JK
Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
[TBL] [Abstract][Full Text] [Related]
20. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
